Main competitors
Dividend Yield (Y) Dividend Yield (Y+1) P/E (Y) Price to Book (Y) EV / Sales (Y) EV / EBITDA (Y) EV / EBIT (Y) Capi.($)
0.62%0.7%16.39x1.91x3.56x9.6x10.51x 64.39B
0.57%0.58%27.8x4.19x5.64x16.51x20.56x 56.12B
-.--%-.--%33.34x6.69x11.27x21.36x25.08x 40.54B
3.59%3.7%-51.07x2.33x3.04x8.99x10.49x 37.98B
-.--%-.--%34.88x1.72x3.71x11.39x13.25x 31.89B
-.--%-.--%-7.78x4.58x11.08x-6.75x-6.41x 26.69B
-.--%-.--%16.77x3.35x3.14x9.51x9.42x 22.73B
-.--%0.06%47.36x4.79x5.16x35.75x33.03x 16.66B
-.--%-.--%25.75x3.64x5.35x14.4x19.9x 16.6B
-.--%-.--%-32.29x-5.6x15.04x-45.74x-47.54x 13.76B
-.--%-.--%-122.61x12800.32x12.51x-110.82x-121.76x 12.44B
0.15%0.16%62.85x25.63x38.19x54.01x55.7x 12B
-.--%-.--%16.75x - 3.57x13.08x15.68x 11.4B
-.--%-.--%48.28x - - - - 10.97B
2.8%3.23%12x1.05x1.82x7.34x9.84x 6.34B
1.78%1.97%12.6x1.16x2.1x5.51x6.58x 5.07B
-.--%-.--%-99.81x - - - - 4.88B
Average 0.56% 0.61% 2.42x 918.27x 8.35x 2.94x 3.62x 22.97B
Weighted average by Cap. 0.61% 0.64% 9.44x 442.01x 7.11x 7.61x 8.99x
Biopharmaceuticals